T. Hong

The Effects of Pioglitazone on Biochemical Markers of Bone Turnover in the Patients with Type 2 Diabetes

Hai-ning Wang, W. Xiao, Yan-rong Wang, 2013, International journal of endocrinology.

Advanced glycosylation end products inhibit the proliferation of bone-marrow stromal cells through activating MAPK pathway

Zheng Li, T. Hong, M. Wan, 2021, European Journal of Medical Research.

Inhibition of hepatic interleukin-18 production by rosiglitazone in a rat model of nonalcoholic fatty liver disease.

Hai-ning Wang, Yan-rong Wang, T. Hong, 2008, World journal of gastroenterology.

Intestinal microbiota changes in Graves’ disease: a prospective clinical study

Z. Lyu, Lin Jiang, Hui Yan, 2020, Bioscience reports.

Mutation analyses in pedigrees and sporadic cases of ethnic Han Chinese Kallmann syndrome patients

Dalong Zhu, Jinkui Yang, J. Dou, 2015, Experimental biology and medicine.

[Ghrelin expression in the tissues of different thyroid diseases].

Hai-ning Wang, T. Hong, Yu-fang Zhang, 2006, Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences.

[The etiological analysis of 260 hospitalized cases with bilateral adrenal lesions].

T. Hong, R. Lu, J. Yang, 2019, Zhonghua yi xue za zhi.

Beneficial metabolic effects of nateglinide versus acarbose in patients with newly-diagnosed type 2 diabetes

Hai-ning Wang, C. Xie, T. Hong, 2007, Acta Pharmacologica Sinica.

Efficacy and Safety of Avandamet or Uptitrated Metformin Treatment in Patients with Type 2 Diabetes Inadequately Controlled with Metformin Alone: A Multicenter, Randomized, Controlled Trial

H. Tian, Ying-li Chen, Jin-kui Yang, 2015, Chinese medical journal.

Initiating Characteristics of Early-onset Type 2 Diabetes Mellitus in Chinese Patients

Jing Yang, Gang-yi Yang, Z. Shan, 2016, Chinese medical journal.